Decitabine Completed Phase 3 Trials for Acute Myeloid Leukemia (AML) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00260832Trial of Decitabine in Patients With Acute Myeloid Leukemia
NCT01303796A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia